- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 311/18 - Benzo [b] pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
Patent holdings for IPC class C07D 311/18
Total number of patents in this class: 129
10-year publication summary
6
|
7
|
7
|
9
|
5
|
7
|
8
|
6
|
11
|
6
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 163 |
6 |
The University of Queensland | 659 |
6 |
Merck Patent GmbH | 5830 |
4 |
Chugai Seiyaku Kabushiki Kaisha | 1354 |
4 |
Allergan, Inc. | 2349 |
3 |
The General Hospital Corporation | 4726 |
3 |
Advanced Liquid Logic, Inc. | 156 |
3 |
H. Lee Moffitt Cancer Center and Research Institute, Inc. | 943 |
3 |
Lead Discovery Center GmbH | 61 |
3 |
NoNO Inc. | 80 |
3 |
Hubei Gurun Technology Co., Ltd | 32 |
3 |
F. Hoffmann-La Roche AG | 7930 |
2 |
The Regents of the University of California | 19898 |
2 |
The Johns Hopkins University | 5667 |
2 |
The Broad Institute, Inc. | 1805 |
2 |
Gachon University of Industry-academic Cooperation Foundation | 297 |
2 |
Immuneering Corporation | 21 |
2 |
Indiana University Research & Technology Corporation | 146 |
2 |
Nippon Zoki Pharmaceutical Co., Ltd. | 142 |
2 |
PTC Therapeutics, Inc. | 483 |
2 |
Other owners | 70 |